Collection: HyalDew

Overcoming the limitations of collagen crosslinking technology applied in conventional HA fillers, it was developed the patented manufacture of micro-pearls using a Multi-Staged Cross-Linking (MCL) technology in three stages in order to create a more stable molecular structure and a higher rate of crosslinking. This solves the problem of the short duration of conventional HA fillers.

Through the use of Biomacromolecules, we have increased the biocompatibility and biological safety to increase the volume, the antibiosis, the anti-inflammatory effect and the anti-adhesion between human tissues. We have achieved the manufacture of HA in a solid state that allows to create laminar forms of anti-adhesives and the creation of stem cell devices for tissue regeneration in solid state using biomacromolecules that are biocompatible and biologically safe.

• Ingredient: Hyaluronic Acid 20mg/mL
• Lidocaine: 0.3%
• Packaging: 1cc * 1 syringe/box